HomeREGULATORY
REGULATORY

MHLW Study Group to Expand Investigation to Clinics to Determine Causes of Improper Promotional Activities
(Aug.22.2017)

Prof. Makoto Shiragami
A study on measures to prevent violations of regulatory compliance by drug makers, which is being funded by the health ministry, has entered its third year. So far, the study group has monitored information provided to hospitals, but this fiscal year it will consider the possibility of monitoring improper information provided to clinics as well to expand monitoring of improper promotional activities ...
(LOG IN FOR FULL STORY)

News Calendar